Similar Results in Liver Transplantation From Controlled Donation After Circulatory Death Donors With Normothermic Regional Perfusion and Donation After Brain Death Donors: A Case‐Matched Single‐Center Study

Patricia Ruiz, Andres Valdivieso, Ibone Palomares, Mikel Prieto, Alberto Ventoso, Patricia Salvador, Maria Senosiain, Jose Ramon Fernandez, Milagros Testillano, Francisco Javier Bustamante, Mikel Gastaca – 28 August 2021 – Although good results have been reported with the use of normothermic regional perfusion (NRP) in controlled donation after circulatory death (cDCD) liver transplantation (LT), there is a lack of evidence to demonstrate similar results to donation after brain death (DBD).

Regulator of G‐protein signaling 14 protects the liver from ischemia–reperfusion injury by suppressing TGF‐β‐activated kinase 1 activation

Jia‐Kai Zhang, Ming‐Jie Ding, Hui Liu, Ji‐Hua Shi, Zhi‐Hui Wang, Pei‐Hao Wen, Yi Zhang, Bing Yan, Dan‐Feng Guo, Xiao‐Dan Zhang, Ruo‐Lin Tao, Zhi‐Ping Yan, Yan Zhang, Zhen Liu, Wen‐Zhi Guo, Shui‐Jun Zhang – 27 August 2021

The Integrated “Multiomics” Landscape at Peak Injury and Resolution From Alcohol‐Associated Liver Disease

Sukanta Das, Xiaodong Ge, Hui Han, Romain Desert, Zhuolun Song, Dipti Athavale, Wei Chen, Harriet Gaskell, Daniel Lantvit, Grace Guzman, Natalia Nieto – 27 August 2021 – Alcohol‐associated liver disease (ALD) is a significant clinical problem for which the most effective therapy is alcohol abstinence. The two aims of this study were, first, to identify the liver transcriptome, fecal microbiome, and portal serum metabolome at peak injury and during early and late resolution from ALD; and second, to integrate their interactions and understand better the pathogenesis of ALD.

Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population

Puru Rattan, Daniel D. Penrice, Joseph C. Ahn, Alejandro Ferrer, Mrinal Patnaik, Vijay H. Shah, Patrick S. Kamath, Abhishek A. Mangaonkar, Douglas A. Simonetto – 27 August 2021 – Physiologic aging leads to attrition of telomeres and replicative senescence. An acceleration of this process has been hypothesized in the progression of chronic liver disease. We sought to examine the association of telomere length (TL) with liver disease and its impact on mortality risk.

Protective Effects of Statin Therapy in Cirrhosis Are Limited by a Common SLCO1B1 Transporter Variant

Melissa Merkel, Christina Schneider, Robin Greinert, Alexander Zipprich, Cristina Ripoll, Frank Lammert, Matthias C. Reichert – 27 August 2021 – Complications of cirrhosis and portal hypertension (PH) can be reduced by statin therapy. The common loss‐of‐function variant p.V174A in the solute carrier organic anion transporter gene 1B1 (SLCO1B1) gene encoding the organic anion transporting polypeptide 1B1 results in decreased hepatic uptake of statins.

Subscribe to